1 Bryan R. Haugen, MD Associate Professor of Medicine University of Colorado Health Sciences Center Past consulting: Abbott Laboratories.

Slides:



Advertisements
Similar presentations
Group on Scientific Research into ME: Neuroendocrinology of CFS/ME Dr Anthony Cleare Reader, Kings College London, Institute of Psychiatry.
Advertisements

L-T 4 Bioequivalence: Potential Impact on IQ in Babies with Congenital Hypothyroidism Rosalind Brown MD, Children’s Hospital, Boston Harvard Medical School.
Potential need for race-specific diagnostic criteria and healthcare delivery for thyroid hormone abnormalities Yutaka Aoki Morgan State University School.
Subclinical Thyroid Disease
Thyroid and Pregnancy a few interesting clinical considerations Ning-Zi Sun GIM PGY-4.
Georges Ghanem MD, FESC, FACC Associate Professor, Chief of Cardiology UMC-RH/LAU-SOM Beirut, Lebanon.
THYROID DISEASE IN PREGNANCY: TREATING TWO PATIENTS Susan J. Mandel, MD MPH Perelman School of Medicine, University of Pennsylvania.
Aggressive Hyperglycemia Management. Significant hospital hyperglycemia requires close follow-up Previously diagnosed diabetes and elevated A1C Without.
Hyperthyroidism: Diagnosis, Management and Long-term Consequences Hyperthyroidism: Diagnosis, Management and Long-term Consequences Kristien Boelaert Senior.
Epoetin Alfa & Increased Mortality Maria Shin, Pharm.D. Pharmacy Resident (PGY-1) Kingsbrook Jewish Medical Center Clinical Instructor of Pharmacy Practice.
Valsartan Antihypertensive Long-Term Use Evaluation Results
CONSENSUS: Cooperative North Scandinavian Enalapril Survival Study Purpose To determine whether the ACE inhibitor enalapril reduces mortality in patients.
SUBCLINICAL HYPERTHYROIDISM Won Bae Kim, M.D., Ph.D. Department of Internal Medicine Asan Medical Center University of Ulsan College of Medicine Seoul,
Impact of “Mild-Subclinical” Thyroid Disease on Cardiovascular Health Harry L. Uy, MD UP College of Medicine Class 1986 Private Practice, Endocrinology.
Subclinical thyroid disease
Thyroid hormones in health and disease Dr S Razvi Endocrinologist and Senior Lecturer 1 st October 2013.
Efficacy and Safety of Dabigatran vs. Warfarin in Patients with Atrial Fibrillation - Japanese population in the RE-LY ® - Shinya Goto, MD., PhD. Tokai.
Is my thyroid making me fat? Justin Moore, MD, FACP Division Chief, Endocrinology and Metabolism Medical Director, Via Christi Weight Management.
When Laboratory Testing Turns Against Us: Human Anti-Mouse Antibody (HAMA) Interference with TSH and PTH Assays Made pics smaller to have your name be.
Underactive thyroid The diagnosis and management of primary hypothyroidism Kristien Boelaert Senior Clinical Lecturer and Consultant Endocrinologist University.
Subclinical thyroid disorders
Levothyroxine Suppressive Therapy in Thyroid Cancer R Michael Tuttle, MD Attending Endocrinologist Assistant Professor of Medicine Memorial Sloan Kettering.
FDA Advisory Committee for Pharmaceutical Science—March 13, 2003 Carlos R. Hamilton, Jr. MD, FACE American Association of Clinical Endocrinologists—Vice.
0902CZR01NL537SS0901 RENAAL Altering the Course of Renal Disease in Hypertensive Patients with Type 2 Diabetes and Nephropathy with the A II Antagonist.
May 2005 EP Show The EP Show COMPANION and CARE-HF Eric Prystowsky MD Director, Clinical Electrophysiology Laboratory St Vincent Hospital Indianapolis,
Subclincal Thyroid Disease and the Work-up of a Thyroid Nodule
The Need for Precise L-Thyroxine Dosing James V. Hennessey M.D. Associate Professor of Medicine Brown Medical School Current, pending and past affiliations:
A 43-year-old woman presents with a two-to-three month history of nervousness, increased sweating, decreased tolerance to heat, palpitations, fatigue,
Diabetes Mellitus 101 for Medical Professionals An Aggressive Pathophysiologic Approach to Cardiometabolic Therapy for Type 2 Diabetes: Stan Schwartz MD,FACP.
S ystolic H eart failure treatment with the I f inhibitor ivabradine T rial Main results Swedberg K, et al. Lancet. 2010;376(9744):
Lower the better; the case for glucose Professor Taner DAMCI Istanbul University Cerrahpaşa Medical School, TURKEY.
Int J MS Care 7: , 2005/2006. Jan 9 & 10, Clinical Stabilization of a MS Patient after Tonsillectomy presented by Michael C. Levin, MD Department.
Hyperglycemia and Acute Coronary Syndromes. Cardiovascular disease and diabetes Bell DSH. Diabetes Care. 2003;26: Centers for Disease Control.
Copyright © 2011 Actelion Pharmaceuticals Ltd SERAPHIN: RESULTS FROM A LANDMARK STUDY.
Peter Deman Henny Janssen.  Subclinical hypothyroidism is frequently found in adults with Down syndrome.  Literature provides no evidence about whether.
Lancet 373: , 2009 Baseline Characteristics of Participants and Study Design of Clinical Trials to Compare Intensive glucose- lowering versus.
AA-2-1 Jerome D. Cohen, MD, FACC, FACP Professor of Internal Medicine / Cardiology Director, Preventive Cardiology Programs St. Louis University Health.
David R. Hunt, MD, FACS Chief Medical Officer and Acting Director, OHITA Office of the National Coordinator for HIT Health IT and Patient Safety: ONC Context.
Prevention of Diabetes Mellitus Prof. Adel El-Etriby Professor of Cardiology Ain Shams Faculty of Medicine.
The Obesity/Diabetes Epidemic: Perspectives, Consequences, Prevention, Treatment Stan Schwartz MD, FACP, FACE Private Practice, Ardmore Obesity Program.
Therapy of Type 2 Diabetes Mellitus: UPDATE Glycemic Goals in the Care of Patients with Type 2 Diabetes ADA and AACE Guidelines: Room For Improvement.
Medical Management of Claudication: Just Walk it Off!!
Small Bowel Toxicity of Nonselective NSAIDs Revealed by Capsule Endoscopy: Results From a Pivotal Clinical Trial Glenn M. Eisen, M.D., M.P.H. Associate.
Effect of Vasodilator Therapy on Mortality in Chronic Congestive Heart Failure Results of a Veterans Administration Cooperative Study (V-HEFT I) Multicenter,
HYPOTHYROIDISM. INTRODUCTION  Hypothyroidism is defined as a deficiency in thyroid hormone secretion and action that produces a variety of clinical signs.
© 2016 American College of Physicians The information contained herein should never be used as a substitute for clinical judgment.
Date of download: 6/25/2016 Copyright © 2016 American Medical Association. All rights reserved. From: The Colorado Thyroid Disease Prevalence Study Arch.
Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated with Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation.
Bonnie Ky, MD, MSCE Assistant Professor of Medicine and Epidemiology
Tina Kochupurackal, D.O., Barry Hoffman, D.O.
An Unusual Case of Graves’ Disease Coexisting with Struma Ovarii Iqra Javeed MD1, Amin Sabet MD2, and Jacqueline Kung MD1 1Division of Endocrinology, Diabetes,
Therapeutic Implications
Hypothyroidism during pregnancy
Lithium Practical Prescribing
Antiplatelet therapy for STEMI: The Case for Clopidogrel
Hypothyroidism management
Efficacy and Safety of Dabigatran vs
Analysis of Current Thyroid Function Test Ordering Practices
Effects of various bisphosphonates on clinical vertebral fractures (A), nonvertebral fractures (B), and hip fractures (C). PLB, placebo; RRR, relative.
Subclinical Hypothyroidism
Family Medicine Refresher Course April 5, 2018
Applying for EU FP7 research funding
The Future Use of Technology in Outpatient Care Using the Computerized Patient Record to Implement Principles of Disease Management: Focus on the.
What’s New in Hypothyroidism?
SUSTAIN-6 Trial design: Patients with DM2 at high risk for CV events were randomized in a 1:1:1:1 fashion to either semaglutide 0.5 mg, semaglutide 1 mg,
Figure 2 Serum levels of TSH and free T4 in a large series
OSLER Trial design: Patients from five phase 2 trials and seven phase 3 trials with evolocumab were invited to participate in the OSLER extension program,
Charles Resnik.
Atrial Fibrillation: An Escalating Cardiovascular Disease With Significant Clinical and Economic Consequences.
Nat. Rev. Endocrinol. doi: /nrendo
Presentation transcript:

1 Bryan R. Haugen, MD Associate Professor of Medicine University of Colorado Health Sciences Center Past consulting: Abbott Laboratories

2 A 62 year-old woman presented with classic symptoms of hypothyroidism Fatigue, weight gain, constipation Fatigue, weight gain, constipation TSH 28 mU/L (0.5-5), T4 8  g/dl (4-12) She was started on 0.1 mg levothyroxine once a day

3 62 year-old hypothyroid woman (TSH 28 mU/L) Eight weeks later: Symptoms improved, but still has significant fatigue –TSH 7 mU/L (0.5-5), T4 9  g/dl (4-12) –Levothyroxine increased to mg a day ( 25%) Eight weeks later: Minimal fatigue, new insomina –TSH 0.08 mU/L

4 Sensitivity of TSH to Change in Dosage of Levothyroxine TSH (  IU/mL) Optimum T 4 (mcg) Carr D, et al. Clin Endocrinol. 1988;28:325. Upper limit of normal Lower limit of normal

5

6 Long-term effects of a low TSH Increased risk of atrial fibrillation (3-fold)Increased risk of atrial fibrillation (3-fold) –Sawin, New Engl J Med 331:1249, 1994 Reduced exercise capacity and cardiac functionReduced exercise capacity and cardiac function –Mercuro, J Clin Endo Metab 85:159, 2000 Decreased BMD and increased fracture risk (3-4x)Decreased BMD and increased fracture risk (3-4x) –DeRosa, Clin Endo 47:529, 1997 –Bauer, Ann Int Med 134:561, 2001 Increased all cause mortality (2-fold), CV mortalityIncreased all cause mortality (2-fold), CV mortality –Parle, Lancet 358:861, 2001

7 Incidence of Atrial Fibrillation (%) Low Thyrotropin Years High Thyrotropin Normal Thyrotropin Slightly Low Thyrotropin Serum Thyrotropin Values at Baseline Sawin CT et al. New Engl J Med. 1994;331:1249.

8 62 year-old hypothyroid woman –TSH 0.08 mU/L on mg LT4 LT4 decreased to mg a day ( 10%) Seven weeks later: She felt well with no complaints –TSH 1.6 mU/L

9 Summary Serum TSH and patient symptoms, not serum T4, are therapeutic endpointsSerum TSH and patient symptoms, not serum T4, are therapeutic endpoints True normal range for TSH is quite narrow (0.5 – 2 mU/L)True normal range for TSH is quite narrow (0.5 – 2 mU/L) Small changes in administered levothyroxine (10-20%) result in significant changes in TSHSmall changes in administered levothyroxine (10-20%) result in significant changes in TSH Abnormal TSH has consequencesAbnormal TSH has consequences –Burden on the patient –Burden on the healthcare system